Literature DB >> 10229755

Early delineation of ischemic tissue in rat brain cryosections by high-contrast staining.

J Vogel1, C Möbius, W Kuschinsky.   

Abstract

BACKGROUND AND
PURPOSE: After short periods of ischemia, commonly used staining methods yield only moderate differences in optical contrast between normal and damaged brain tissue when gray-scale images are used for computer-assisted image analysis. We describe a high-contrast silver infarct staining (SIS) method that allows an early delineation of ischemic tissue as soon as 2 hours after middle cerebral artery occlusion (MCAO) in rat brain cryosections.
METHODS: Rats were subjected to permanent MCAO for 2, 4, 6, and 48 hours. The optical densities were quantified in nonischemic white and gray matter and in damaged tissue from gray-scale images of serial sections with the use of a video camera-based image analyzing system. SIS, hematoxylin-eosin, Nissl, and nitroblue tetrazolium stainings were performed in cryosections, and 2,3, 5-triphenyltetrazolium hydrochloride (TTC) staining was performed in unfrozen vibratome sections. In addition, the range of reduced cerebral blood flow (CBF) in areas demarcated by SIS was determined in iodo[14C]antipyrine autoradiograms of adjacent cryosections.
RESULTS: At all times after MCAO, only SIS showed significantly (P<0.01) lower optical densities in damaged than in normal brain tissue for both white and gray matter. TTC staining was as effective as SIS 6 and 48 hours after MCAO. The tightest correlation between areas of reduced SIS and of reduced CBF was found at a mean ischemic CBF of 22.3 mL/100 g per minute. This corresponds to a CBF range of 0 to 44 mL/100 g per minute in areas of reduced SIS.
CONCLUSIONS: In contrast to other staining methods, SIS allows a reliable delineation of ischemic brain tissue (core plus penumbra) from nonischemic white and gray matter of rat brain cryosections as soon as 2 hours after MCAO.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10229755     DOI: 10.1161/01.str.30.5.1134

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  24 in total

Review 1.  Visualizing cell death in experimental focal cerebral ischemia: promises, problems, and perspectives.

Authors:  Marietta Zille; Tracy D Farr; Ingo Przesdzing; Jochen Müller; Clemens Sommer; Ulrich Dirnagl; Andreas Wunder
Journal:  J Cereb Blood Flow Metab       Date:  2011-11-16       Impact factor: 6.200

2.  Glyceraldehyde-3-phosphate dehydrogenase versus toluidine blue as a marker for infarct volume estimation following permanent middle cerebral artery occlusion in mice.

Authors:  Bettina H Clausen; Kate L Lambertsen; Bente Finsen
Journal:  Exp Brain Res       Date:  2006-05-24       Impact factor: 1.972

3.  Electroporation of the hindbrain to trace axonal trajectories and synaptic targets in the chick embryo.

Authors:  Ayelet Kohl; Yoav Hadas; Avihu Klar; Dalit Sela-Donenfeld
Journal:  J Vis Exp       Date:  2013-05-29       Impact factor: 1.355

4.  Adult responses to an ischemic stroke in a rat model of neonatal stress and morphine treatment.

Authors:  Sarah L Hays; Olga A Valieva; Ronald J McPherson; Sandra E Juul; Christine A Gleason
Journal:  Int J Dev Neurosci       Date:  2012-09-28       Impact factor: 2.457

5.  CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons.

Authors:  A Martin-Villalba; I Herr; I Jeremias; M Hahne; R Brandt; J Vogel; J Schenkel; T Herdegen; K M Debatin
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

6.  Evidence that meningeal mast cells can worsen stroke pathology in mice.

Authors:  Ahmet Arac; Michele A Grimbaldeston; Andrew R B Nepomuceno; Oluwatobi Olayiwola; Marta P Pereira; Yasuhiro Nishiyama; Anna Tsykin; Gregory J Goodall; Ulrich Schlecht; Hannes Vogel; Mindy Tsai; Stephen J Galli; Tonya M Bliss; Gary K Steinberg
Journal:  Am J Pathol       Date:  2014-09       Impact factor: 4.307

7.  Short period of early reperfusion aggravates blood-brain barrier dysfunction during permanent focal ischemia in rats.

Authors:  Johannes Woitzik; Axel Hohenstein; Nils Hecht; Eric Juettler; Lothar Schilling
Journal:  Transl Stroke Res       Date:  2010-09-04       Impact factor: 6.829

8.  G-CSF, rt-PA and combination therapy after experimental thromboembolic stroke.

Authors:  Rainer Kollmar; Nils Henninger; Christian Urbanek; Stefan Schwab
Journal:  Exp Transl Stroke Med       Date:  2010-04-14

9.  Simultaneous multispectral reflectance imaging and laser speckle flowmetry of cerebral blood flow and oxygen metabolism in focal cerebral ischemia.

Authors:  Phill B Jones; Hwa Kyoung Shin; David A Boas; Bradley T Hyman; Michael A Moskowitz; Cenk Ayata; Andrew K Dunn
Journal:  J Biomed Opt       Date:  2008 Jul-Aug       Impact factor: 3.170

10.  Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke.

Authors:  Arthur Liesz; Elisabeth Suri-Payer; Claudia Veltkamp; Henrike Doerr; Clemens Sommer; Serge Rivest; Thomas Giese; Roland Veltkamp
Journal:  Nat Med       Date:  2009-01-25       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.